A major shareholder is urging biotechnology firm Northwest Biotherapeutics to hold an inquiry into allegations about the governance of the company by Chairwoman and Chief Executive Linda Powers.
from WSJ.com: US Business http://ift.tt/1HxNz7D
via IFTTT
No comments:
Post a Comment